Green Cross Holdings Corp
005257
Company Profile
Business description
Green Cross Holdings Corp manufactures and sells medicines and medical supplies. The company's products include Plasma Derivatives, Vaccines, Prescription Drugs and Over-the-counter Drugs. Some of the drugs offered by the company comprise of Acustop Cataplasma, Zenol Cool Type, Green-VIII inj and Hunterase.
Contact
107 , Ihyeon-ro
30beon-gil, Giheung-gu
Gyeonggi-do
Yongin-si,16924
KORT: +82 312609300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
155
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
Qantas’ budget brand performing well, with segment earnings up 55%.
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,040.10 | 87.10 | -0.95% |
| CAC 40 | 7,654.25 | 53.65 | -0.70% |
| DAX 40 | 23,487.33 | 550.00 | -2.29% |
| Dow JONES (US) | 45,295.81 | 249.07 | -0.55% |
| FTSE 100 | 9,116.69 | 79.65 | -0.87% |
| HKSE | 25,381.57 | 114.98 | -0.45% |
| NASDAQ | 21,279.63 | 175.92 | -0.82% |
| Nikkei 225 | 42,035.72 | 274.77 | -0.65% |
| NZX 50 Index | 13,049.69 | 83.47 | -0.64% |
| S&P 500 | 6,415.54 | 44.72 | -0.69% |
| S&P/ASX 200 | 8,768.10 | 90.90 | -1.03% |
| SSE Composite Index | 3,820.98 | 37.15 | -0.96% |